Beyond fecal abundance: defining the active therapeutic entity in Bifidobacterium-mediated protection against Klebsiella-driven MASLD
Journal of Gastroenterology · 28.10.2026
DOI: 10.1007/s00535-026-02531-0 ↗Kurz gefasst
Leserbrief in der Zeitschrift Journal of Gastroenterology, online erschienen am 28.10.2026. Verfasst von Kaan Zıkşahna und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Basic Medical Sciences, Faculty of Medicine, Biruni University, Istanbul, Turkey. Die Arbeit nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Basic Medical Sciences, Faculty of Medicine, Biruni University, Istanbul, Turkey.
- Department of Bioengineering, Faculty of Chemical and Metallurgical Engineering, Yildiz Technical University, Istanbul, Turkey.
- Department of Electronics and Automation, Vocational School, Biruni University, Istanbul, Turkey. mihlamur@biruni.edu.tr.
- Biruni University Advanced Technology and Research Center (B@MER), Biruni University, Istanbul, Turkey. mihlamur@biruni.edu.tr.
Zitieren
APA
Zıkşahna, K., & Ihlamur, M. (2026). Beyond fecal abundance: defining the active therapeutic entity in Bifidobacterium-mediated protection against Klebsiella-driven MASLD. Journal of Gastroenterology. https://doi.org/10.1007/s00535-026-02531-0
Vancouver
Zıkşahna K, Ihlamur M. Beyond fecal abundance: defining the active therapeutic entity in Bifidobacterium-mediated protection against Klebsiella-driven MASLD. Journal of Gastroenterology. 2026. doi:10.1007/s00535-026-02531-0
BibTeX
@article{Zkahna2026,
author = {Zıkşahna, Kaan and Ihlamur, Murat},
title = {Beyond fecal abundance: defining the active therapeutic entity in Bifidobacterium-mediated protection against Klebsiella-driven MASLD},
journal = {Journal of Gastroenterology},
year = {2026},
doi = {10.1007/s00535-026-02531-0}
}
EUVIMED